Visual evoked potentials in succinate semialdehyde dehydrogenase (SSADH) deficiency

Journal of Inherited Metabolic Disease

Volumn 32, Issue SUPPL. 1, 2009, Pages

  Di Rosa, G ^a   Malaspina, P ^b   Blasi, P ^b   Dionisi Vici, C ^c   Rizzo, C ^c   Tortorella, G ^a   Crutchfield, S R ^d   Gibson, K M ^e,f  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; 4-HYDROXYBUTYRIC ACID; ALDH5A1 PROTEIN, HUMAN; HEXANOIC ACID DERIVATIVE; HYDROXYBUTYRIC ACID; SUCCINATE SEMIALDEHYDE DEHYDROGENASE;

ADULT; ARTICLE; CASE REPORT; CHILD; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; ENZYMOLOGY; EVOKED VISUAL RESPONSE; FEMALE; GENETICS; HUMAN; MALE; MUTATION; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; URINE;

ADULT; AMINO ACID METABOLISM, INBORN ERRORS; CAPROATES; CHILD; CHILD, PRESCHOOL; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; HYDROXYBUTYRATES; MALE; MUTATION; SUCCINATE-SEMIALDEHYDE DEHYDROGENASE;

EID: 84880981906     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-009-1154-4     Document Type: Article

References (29)

1. Akaboshi S, Hogema BM, Novelletto A, et al (2003) Mutational spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1) gene and functional analysis of 27 novel disease-causing mutations in patients with SSADH deficiency. Hum Mutat 22: 442-450. doi:10.1002/humu.10288 (Pubitemid 38009947)
2. Blasi P, Boyl PP, Ledda M, et al (2002) Structure of human succinic semialdehyde dehydrogenase gene: identification of promoter region and alternatively processed isoforms. Mol Genet Metab 76: 348-362. doi:10.1016/S1096-7192(02)00105-1
3. Bradfield YS, France TD, Verhoeve J, Gangnon RE (2007) Sweep visual evoked potential testing as a predictor of recognition acuity in albinism. Arch Ophthalmol 125: 628-633. doi:10.1001/archopht.125.5.628 (Pubitemid 46762723)
4. Brown GK, Cromby CH, Manning NJ, Pollitt RJ (1987) Urinary organic acids in succinic semialdehyde dehydrogenase deficiency: evidence of alpha-oxidation of 4-hydroxybutyric acid, interaction of succinic semialdehyde with pyruvate dehydrogenase and possible secondary inhibition of mitochondrial beta-oxidation. J Inherit Metab Dis 10: 367-375. doi:10.1007/BF01799979 (Pubitemid 18009388)
5. Buzzi A, Wu Y, Frantseva MV, et al (2006) Succinic semialdehyde dehydrogenase deficiency: GABAB receptormediated function. Brain Res 1090: 15-22. doi:10.1016/j.brainres.2006.02.131 (Pubitemid 43817924)
6. Celesia GG, Peachey NS (1999) Visual evoked potentials and electroretinograms. In: Electroencephalography. Basic Principles, Clinical Applications, and Related Fields. Niedermeyer E, Lopes Da Silva F, eds. Baltimore: Lippincott Williams & Wilkins, 968-993.
7. Chu NS (1986) Sensory evoked potentials in Wilson-s disease. Brain 109(3): 491-507.
8. Crutchfield SR, Harding GFA, Durbin GM (1986) Contiguous and serial recordings of BAEPs and VEPs in premature infants who did and did not sustain hemorrhage and/or periventricular leukomalacia. In: Gallai V, ed. Maturation of the CNS and Evoked Potentials. New York: Excerpta Medica.
9. Crutchfield SR, Haas RH, Nyhan WL, Gibson KM (2008) Succinic semialdehyde dehydrogenase deficiency: phenotype evolution in an adolescent patient at 20-year follow-up. Dev Med Child Neurol 50: 880-881.
10. Das M, Misra UK, Kalita J (2007) A study of clinical, MRI and multimodality evoked potentials in neurologic Wilson disease. Eur J Neurol 14: 498-504. doi:10.1111/j.1468-1331.2006.01676.x
11. Eggers ED, Lukasiewicz PD (2006) GABA(A), GABA(C) and glycine receptor-mediated inhibition differentially affects light-evoked signaling from mouse retinal rod bipolar cells. J Physiol 572: 215-225.
12. Gibson KM, Hoffmann G, Nyhan WL, et al (1988) 4-Hydroxybutyric aciduria in a patient without ataxia or convulsions. Eur J Pediatr 147: 529-531. doi:10.1007/BF00441983
13. Gibson KM, Gupta M, Pearl PL, et al (2003) Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria). Biol Psychiatry 54: 763-768. doi:10.1016/S0006-3223(03)00113-6 (Pubitemid 37281394)
14. Hammoudi DS, Lee SS, Madison A, et al (2005) Reduced visual function associated with infantile spasms in children on vigabatrin therapy. Invest Ophthalmol Vis Sci 46: 514-520. doi:10.1167/iovs.04-0559 (Pubitemid 40270329)
15. Harding GF, Wild JM, Robertson KA, et al (2000) Electrooculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with vigabatrin-attributed visual field constriction. Epilepsia 41: 1420-1431. doi:10.1111/j.1528-1157.2000.tb00117.x
16. Hinton T, Chebib M, Johnston GA (2008) Enantioselective actions of 4-amino-3-hydroxybutanoic acid and (3-amino-2-hydroxypropyl)methylphosphinic acid at recombinant GABA(C) receptors. Bioorg Med Chem Lett 18: 402-404. doi:10.1016/j.bmcl.2007.10.019
17. Hoffmann MB, Seufert PS, Schmidtborn LC (2007) Perceptual relevance of abnormal visual field representations: static visual field perimetry in human albinism. Br J Ophthalmol 91: 509-513. doi:10.1136/bjo.2006.094854 (Pubitemid 46623687)
18. Hrbek A, Iversen K, Olsson T (1982) Evaluation of cerebral function in newborn infants with fetal growth retardation. Adv Neurol 32: 89-95.
19. Husain AM (2006) Neurophysiologic studies in Krabbe disease. Suppl Clin Neurophysiol 59: 289-298.
20. Jones EG (1986) Neurotransmitters in the cerebral cortex. J Neurosurg 65: 135-153.
21. Lawden MC, Eke T, Degg C, Harding GF, Wild JM (1999) Visual field defects associated with vigabatrin therapy. J Neurol Neurosurg Psychiatry 67: 716-722. doi:10.1136/jnnp.67.6.716
22. Lukasiewicz PD, Shields CR (1998) Different combinations of GABAA and GABAC receptors confer distinct temporal properties to retinal synaptic responses. J Neurophysiol 79: 3157-3167. (Pubitemid 28317042)
23. Nevsímalová S, Ponca I, Fiksa J (1990) Visual and somatosensory evoked potentials in hereditary motor-sensory neuropathies. Schweiz Arch Neurol Psychiatr 141(3): 217-228. (Pubitemid 20232038)
24. Novotny EJ, Jr., Fulbright RK, Pearl PL, Gibson KM, Rothman DL (2003) Magnetic resonance spectroscopy of neurotransmitters in human brain. Ann Neurol 54 Supplement 6: S25-31. doi:10.1002/ana.10697 (Pubitemid 36903851)
25. Pearl PL, Taylor J, Trzcinski S, et al. (2007) 11C - Flumazenil PET Imaging in Patients with SSADH Deficiency. Program No. 2.140. Abstract Viewer. Philadelphia, PA: American Epilepsy Society.
26. Reis J, Cohen LG, Pearl PL, Gibson KM, Dustin I, Theodore WH (2007) Transcranial Magnetic Stimulation reveals altered Cortical Excitability in Succinic Semialdehyde Dehydrogenase Deficiency. Program No. 3.029. Abstract Viewer. Philadelphia, PA: American Epilepsy Society.
27. Saletu B, Saletu M, Simeon J, Viamontes G, Itil TM (1975) Comparative symptomatological and evoked potential studies with d -amphetamine, thioridazine, and placebo in hyperkinetic children. Biol Psychiatry 10 : 253-275.
28. Schroeder CE, Gibson JP, Yarrington J, Heydorn WE, Sussman NM, Arezzo JC (1992) Effects of high-dose gamma-vinyl GABA (vigabatrin) administration on visual and somatosensory evoked potentials in dogs. Epilepsia 33Supplement 5: S13-25. doi:10.1111/j.1528-1157.1992.tb05896.x
29. Wu Y, Buzzi A, Frantseva MV, et al (2006) Status epilepticus in mice deficient for succinate semialdehyde dehydrogenase: GABAA receptor-mediated mechanisms. Ann Neurol 59: 42-52. doi:10.1002/ana.20686 (Pubitemid 43042870)